Medicines and Healthcare products Regulatory Agency
| 1: Authorisation Number | UK MIA(IMP) 30013 | 
|---|---|
| 2: Name of authorisation holder | PHARMARON BIOLOGICS (UK) LTD | 
| 3: Address(es) of manufacturing site(s) | PHARMARON BIOLOGICS (UK) LTD, NATIONAL BIOMANUFACTURING CENTRE, ESTUARY BANKS, ESTUARY COMMERCE PARK, SPEKE ROAD, LIVERPOOL, L24 8RB, UNITED KINGDOM | 
| 4: Legally registered address of authorisation holder | PHARMARON BIOLOGICS (UK) LTD, NATIONAL BIOMANUFACTURING CENTRE, ESTUARY BANKS, ESTUARY COMMERCE PARK, SPEKE ROAD, LIVERPOOL, L24 8RB, UNITED KINGDOM | 
| 5: Scope of authorisation and dosage forms | ANNEX 1 and/ or ANNEX 2 | 
| 6: Legal Basis of authorisation | |
| 7: Name of responsible officer of the competent authority of the member state granting the manufacturing authorisation | Confidential | 
| 8: Authorisation Date | 03/03/2022 | 
| 9: Annexes attached | Annex 1 and/or Annex 2 | 
SCOPE OF AUTHORISATION
        Annex 2
        
          Name and address of the site: 
          
      
              
          
  
        
        
        PHARMARON BIOLOGICS (UK) LTD, NATIONAL BIOMANUFACTURING CENTRE, ESTUARY BANKS, ESTUARY COMMERCE PARK, SPEKE ROAD, LIVERPOOL, L24 8RB, UNITED KINGDOM
                                          Human Investigational Medicinal Products
                  
      | Authorised Operations | 
| MANUFACTURING OPERATIONS (according to part 1)IMPORTATION OF MEDICINAL PRODUCTS (according to part 2) | 
| Part 1 - MANUFACTURING OPERATIONS | 
| [ 1.1 ] Sterile Investigational Medicinal Products | 
| [ 1.1.3 ] Batch certification | 
| [ 1.2 ] Non-sterile investigational medicinal products | 
| [ 1.2.2 ] Batch certification | 
| [ 1.3 ] Biological investigational medicinal products | 
| [ 1.3.1 ] Biological medicinal products | 
| [ 1.3.1.2 ] Immunological products | 
| [ 1.3.1.3 ] Cell therapy products | 
| [ 1.3.1.4 ] Gene therapy products | 
| [ 1.3.1.5 ] Biotechnology products | 
| [ 1.3.1.6 ] Human or animal extracted products | 
| [ 1.3.1.8 ] Other biological medicinal products Biological Active Starting Materials | 
| [ 1.6 ] Quality control testing | 
| [ 1.6.2 ] Microbiological: non-sterility | 
| [ 1.6.3 ] Chemical/Physical | 
| [ 1.6.4 ] Biological | 
| Part 2 - IMPORTATION OF MEDICINAL PRODUCTS | 
| [ 2.2 ] Batch certification of imported medicinal products | 
| [ 2.2.1 ] Sterile Products | 
| [ 2.2.1.1 ] Aseptically prepared | 
| [ 2.2.1.2 ] Terminally sterilised | 
| [ 2.2.2 ] Non-sterile products | 
| [ 2.2.3 ] Biological medicinal products | 
| [ 2.2.3.2 ] Immunological products | 
| [ 2.2.3.3 ] Cell therapy products | 
| [ 2.2.3.4 ] Gene therapy products | 
| [ 2.2.3.5 ] Biotechnology products | 
| [ 2.2.3.6 ] Human or animal extracted products | 
| [ 2.2.3.8 ] Other biological medicinal products Biological Active Starting Materials | 
